American Society for Radiation Oncology (ASTRO) 2022 Annual Meeting - Results from #20

Viewing 21-40 of 54 articles

ASTRO 2022: GETUG-AFU 22 Phase II Randomized Trial Evaluating Outcomes of Post-Operative Immediate Salvage Radiation Therapy with or without ADT for Patients with Persistently Elevated PSA Level

ASTRO 2022: Focal MR-Guided High-Dose-Rate Brachytherapy for Localized Prostate Cancer: A Prospective Clinical Trial

ASTRO 2022: The Accuracy of Multiparametric MRI in Identification of Intraprostatic Tumor Deposits after Local Prostate Radiation Therapy

ASTRO 2022: Challenges and Solutions During the COVID Pandemic for Patient Retention and Physician Engagement in the Phase 3 ATLAS Study of Apalutamide Added to ADT in High-Risk Localized or Locally Advanced Prostate Cancer

ASTRO 2022: Development and Validation of a Multivariable Prognostic Model in De Novo Metastatic Castrate Sensitive Prostate Cancer: Exploring Potential Avenue for Risk Stratification and Treatment Personalization

ASTRO 2022: Patterns of Care after 68Ga-PSMA-PET in Patients with Radiorecurrent Localized Only Prostate Cancer

ASTRO 2022: Kinetics and Patterns of PSMA PET Uptake in Prostate Cancer after Radiation Therapy: A Single Center Retrospective Study

ASTRO 2022: The Use of Hyaluronic Acid As Rectal Spacer in Prostate Cancer Patients Undergoing Hypofractionated Radiotherapy: An Australian Experience

ASTRO 2022: The Association Between Dose Escalation and Risk of Developing Metastases in Intermediate and High Risk Prostate Cancer Patients Treated with Radiotherapy

ASTRO 2022: The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analysis

ASTRO 2022: Long-Term Outcomes of Patients on a Phase II Prospective Trial of Oligometastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and External Beam Radiation

ASTRO 2022: Correlation Between Obesity and Treatment Failure Following Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer

ASTRO 2022: Randomized Trial of 18F-fluciclovine vs. 68Ga-PSMA PET/CT Guided Post-Prostatectomy Radiotherapy: Interim Volumetric and Toxicity Analyses

ASTRO 2022: Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103

ASTRO 2022: Toxicity Analysis of Patients with Prostate Cancer Treated with 3D-Conformal Compared to Intensity Modulated Radiotherapy: Secondary Analysis of RTOG 0126 and RTOG 0415

ASTRO 2022: A Pilot Study of Salvage HDR Brachytherapy in Recurrent Prostate Cancer: 5 Year Toxicity and Outcomes

ASTRO 2022: Using Molecular Imaging to Create Guidelines for the Optimal Clinical Target Volume for Para-Aortic Lymph Nodes in Prostate Cancer

ASTRO 2022: Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer

ASTRO 2022: Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results

ASTRO 2022: Abiraterone, ADT, and Radiotherapy for Localized Intermediate/High Risk Prostate Cancer: Long-Term Follow-Up of the RAD1 Phase 2 Trial

1
2
3

email news signup